Evidence map›Paper›PMID 42474508›Full record

ReviewWorld journal of urology2026

Tumor microenvironment-mediated hematologic toxicity of

Ziye Wang, Daihui Xiao, Bo Wang, Wen Tang, Guobiao Liang, Tao Wu

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ziye Wang *Department of Urology, The Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Daihui Xiao *Department of Urology, The Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Bo WangDepartment of Urology, The Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Wen TangDepartment of Urology, The Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Guobiao LiangDepartment of Urology, The Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Tao WuDepartment of Urology, The Affiliated Hospital of Zunyi Medical University, Zunyi, China. martin0600@163.com.

Funding

Guizhou Provincial Science and Technology Department grant no. ZK2022665
6 · The paper itself

Abstract

objectiveThis studyaims to systematically elucidate the mechanisms underlying hematologic toxicity in

methodsBy integrating and analyzing existing clinical and mechanistic research evidence, a "triple-hit" toxicity mechanism model was proposed. Based on this, key risk factors were identified, risk stratification criteria were established, and a structured clinical management pathway encompassing prevention, monitoring, and intervention was developed.

resultsThe hematologic toxicity of

conclusionA thorough understanding of the triple-hit mechanism and implementation of risk stratification management facilitate safer and more effective application of

Indexed as

ActiniumDipeptidesHeterocyclic Compounds, 1-RingProstatic Neoplasms, Castration-ResistantRadiopharmaceuticalsTumor MicroenvironmentHumansMaleProstate-Specific AntigenRisk Assessment(225)Ac-PSMA-617ActiniumDipeptidesHeterocyclic Compounds, 1-RingProstate-Specific AntigenRadiopharmaceuticals225Ac-PSMA-617Clinical managementHematological toxicityMetastatic castration-resistant prostate cancer (mCRPC)Risk stratificationTumor microenvironment (TME)

Identifiers

PMID42474508

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.